MeSH D019052 - postpartum depression
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Biogen | Zuranolone | Zurzuvae | 2034-04-17 | 2023-10-31 | $36.9 M | Y2024 |
| Sage Therapeutics | Brexanolone | Zulresso | 2029-03-13 | 2019-06-17 |
Clinical Trials
Historical Success Rate
Phase 1
50%2/4
Phase 2
67%12/18
Phase 3
29%4/14
Approved: 1Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use